- Filed
- Mar 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 21, 2025 | 5.23M sh |
| Shares Diluted | FY 2024 · Dec 31, 2024 | 1.9K sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 1.07K sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2024 | −$26.13M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$40.45M |
| Cash And Equivalents | FY 2024 · Dec 31, 2024 | $4.99M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $12.78M |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | $2.72M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $11.22M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $47.67M |
| Current Liabilities | FY 2024 · Dec 31, 2024 | $5.28M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $5.61M |
| Total Liabilities | FY 2024 · Dec 31, 2024 | $5.28M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $7M |
| Current Assets | FY 2024 · Dec 31, 2024 | $6.41M |
| Current Assets | FY 2024 · Dec 31, 2023 | $14.73M |
| Total Assets | FY 2024 · Dec 31, 2024 | $8.01M |
| Total Assets | FY 2024 · Dec 31, 2023 | $18.22M |
| Eps Diluted | FY 2024 · Dec 31, 2024 | −$15.85 |
| Eps Diluted | FY 2024 · Sep 30, 2024 | −$15.85 |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$37.72 |
| Eps Diluted | FY 2024 · Sep 30, 2023 | −$37.72 |
| Eps Basic | FY 2024 · Dec 31, 2024 | −$15.85 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$37.72 |
| Sga Expense | FY 2024 · Dec 31, 2024 | $15.98M |
| Sga Expense | FY 2024 · Dec 31, 2023 | $13.64M |
| Net Income | FY 2024 · Dec 31, 2024 | −$30.07M |
| Net Income | FY 2024 · Dec 31, 2023 | −$40.16M |
| Operating Income | FY 2024 · Dec 31, 2024 | −$31.46M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$42.61M |